Abstract
INTRODUCTION: In liver transplantation, up to 10% of early liver failures are caused by ischemia and reperfusion (IR) injury, with a higher incidence of acute and chronic rejection, thus increasing the need for re-transplantation. Oxidative stress as well as the inflammatory process are important mechanisms of cell injury. In this context, drugs with anti-inflammatory, anti-fibrotic and a…